Furthermore, we address the potential influence of ATX, LPA receptors, and LPP3 on obesity-related comorbidities, including fatty liver disease and cardiomyopathy. This evidence concerns the gene PLPP3 and obesity due to melanocortin 4 receptor deficiency.